Hyereen Kang

488 total citations
18 papers, 399 citations indexed

About

Hyereen Kang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hyereen Kang has authored 18 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Hyereen Kang's work include Protease and Inhibitor Mechanisms (7 papers), Inflammasome and immune disorders (3 papers) and Estrogen and related hormone effects (3 papers). Hyereen Kang is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Inflammasome and immune disorders (3 papers) and Estrogen and related hormone effects (3 papers). Hyereen Kang collaborates with scholars based in South Korea, United States and Ethiopia. Hyereen Kang's co-authors include Jesang Ko, Sung-Wuk Jang, Sung‐Wuk Jang, MinJae Lee, Yoon Suk Kim, Jhang Ho Pak, Sungbo Shim, Kyung‐Chul Choi, Min Jae Lee and Ho Joong Sung and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Hyereen Kang

18 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyereen Kang South Korea 11 230 77 67 63 56 18 399
Elham Ghadami Iran 9 251 1.1× 115 1.5× 27 0.4× 53 0.8× 43 0.8× 14 426
Sasikumar J. Soumya India 5 246 1.1× 83 1.1× 19 0.3× 54 0.9× 49 0.9× 8 440
Nashwa Kabil United States 12 307 1.3× 155 2.0× 40 0.6× 147 2.3× 88 1.6× 19 540
Ligang Jie China 11 211 0.9× 73 0.9× 39 0.6× 81 1.3× 80 1.4× 26 401
Carina Walpole Australia 14 188 0.8× 103 1.3× 37 0.6× 123 2.0× 116 2.1× 28 502
Dong‐Qing Hu United States 13 329 1.4× 69 0.9× 20 0.3× 35 0.6× 85 1.5× 31 709
Natthakan Thongon United States 11 296 1.3× 86 1.1× 22 0.3× 50 0.8× 31 0.6× 20 413
Shengchao Lin China 11 296 1.3× 201 2.6× 56 0.8× 74 1.2× 62 1.1× 12 497

Countries citing papers authored by Hyereen Kang

Since Specialization
Citations

This map shows the geographic impact of Hyereen Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyereen Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyereen Kang more than expected).

Fields of papers citing papers by Hyereen Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyereen Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyereen Kang. The network helps show where Hyereen Kang may publish in the future.

Co-authorship network of co-authors of Hyereen Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hyereen Kang. A scholar is included among the top collaborators of Hyereen Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyereen Kang. Hyereen Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kang, Hyereen, Seong Woo Choi, Joo‐Young Kim, et al.. (2024). ER-to-lysosome Ca2+ refilling followed by K+ efflux-coupled store-operated Ca2+ entry in inflammasome activation and metabolic inflammation. eLife. 12. 4 indexed citations
2.
Park, Kihyoun, Injae Shin, Hyereen Kang, et al.. (2024). A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout. Frontiers in Immunology. 14. 8 indexed citations
3.
Kang, Hyereen, Seong Woo Choi, Joo‐Young Kim, et al.. (2023). ER-to-lysosome Ca2+ refilling followed by K+ efflux-coupled store-operated Ca2+ entry in inflammasome activation and metabolic inflammation. eLife. 12. 2 indexed citations
4.
Kang, Hyereen, et al.. (2023). 755 The risk of inflammation and fibrosis in the skin microenvironment through skin penetration by nanoplastics. Journal of Investigative Dermatology. 143(5). S130–S130. 1 indexed citations
5.
Kim, Jinyoung, Seong‐Hun Kim, Hyereen Kang, et al.. (2021). TFEB–GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response. Nature Metabolism. 3(3). 410–427. 53 indexed citations
6.
Oh, Chang-ki, Hyereen Kang, Ji Won Um, et al.. (2016). Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration. Cell Death and Disease. 7(6). e2240–e2240. 10 indexed citations
7.
Kang, Hyereen, Sung‐Wuk Jang, Jhang Ho Pak, & Sungbo Shim. (2015). Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation. Molecular and Cellular Biochemistry. 403(1-2). 85–94. 27 indexed citations
8.
Park, Eunsoo, Hyereen Kang, Jeonghan Kim, & Jesang Ko. (2014). The Role of sLZIP in Transcriptional Regulation of c-Jun and Involvement in Migration and Invasion of Cervical Cancer Cells. Cellular Physiology and Biochemistry. 33(1). 151–164. 9 indexed citations
9.
Kang, Hyereen & Sung‐Wuk Jang. (2014). Roles of Matrix Metalloproteinase-9 in Cancer Metastasis. Journal of Experimental & Biomedical Sciences/Biomedical Science Letters. 20(3). 103–110. 2 indexed citations
10.
Lee, MinJae, Hyereen Kang, & Sung‐Wuk Jang. (2013). CoCl2 induces PC12 cells apoptosis through p53 stability and regulating UNC5B. Brain Research Bulletin. 96. 19–27. 11 indexed citations
11.
Kang, Hyereen, MinJae Lee, & Sung‐Wuk Jang. (2013). Celastrol inhibits TGF-β1-induced epithelial–mesenchymal transition by inhibiting Snail and regulating E-cadherin expression. Biochemical and Biophysical Research Communications. 437(4). 550–556. 50 indexed citations
12.
13.
Kang, Hyereen, Jesang Ko, & Sung-Wuk Jang. (2012). The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. Biochemical and Biophysical Research Communications. 423(1). 188–194. 42 indexed citations
14.
Kang, Hyereen, Sung-Wuk Jang, & Jesang Ko. (2011). Human Leucine Zipper Protein sLZIP Induces Migration and Invasion of Cervical Cancer Cells via Expression of Matrix Metalloproteinase-9. Journal of Biological Chemistry. 286(49). 42072–42081. 26 indexed citations
15.
Kang, Hyereen, et al.. (2011). Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-ĸB-mediated Matrix Metalloproteinase-9 Expression. Cellular Physiology and Biochemistry. 28(2). 175–184. 76 indexed citations
16.
Kang, Hyereen, Yoon Suk Kim, & Jesang Ko. (2009). A Novel Isoform of Human LZIP Negatively Regulates the Transactivation of the Glucocorticoid Receptor. Molecular Endocrinology. 23(11). 1746–1757. 20 indexed citations
17.
Sung, Ho Joong, Yoon Suk Kim, Hyereen Kang, & Jesang Ko. (2008). Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migration. Experimental & Molecular Medicine. 40(3). 332–332. 15 indexed citations
18.
Gürateş, Bilgin, et al.. (2005). Expression of cyclooxygenase-2 in endometrial adenocarcinoma.. PubMed. 26(3). 271–4. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026